AVEO Oncology
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.aveoncology.comRevenue
<$5 MillionIndustry
About AVEO Oncology
AVEO Oncology Org Chart
Is AVEO Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
AVEO Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on AVEO Oncology recently announced quarterly report
Check out if AVEO Oncology is spiking on competitors!
Click to see if AVEO Oncology had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at AVEO Oncology
Funding: Get notified immidiatlly once AVEO Oncology has new funding data
Check if AVEO Oncology has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when AVEO Oncology launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
AVEO Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AVEO Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AVEO Oncology.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AVEO Oncology
Aveo Oncology is an oncology-focused biopharmaceutical company dedicated to developing innovative medicines aimed at improving the lives of cancer patients. The company is committed to providing effective solutions and is a part of LG Chem. Their product line includes treatments such as FOTIVDA, Ficlatuzumab, and AV-380. Aveo Oncology seeks to part... Read More